Patients with multidrug-resistant tuberculosis display impaired Th1 responses and enhanced regulatory T-cell levels in response to an outbreak of multidrug-resistant Mycobacterium tuberculosis M and Ra strains

Infection and Immunity

Volumn 77, Issue 11, 2009, Pages 5025-5034

  Geffner, Laura ^a   Yokobori, Noemí ^a   Basile, Juan ^a   Schierloh, Pablo ^a   Balboa, Luciana ^a   Romero, María Mercedes ^a   Ritacco, Viviana ^b   Vescovo, Marisa ^c   Montaner, Pablo González ^c   Lopez, Beatriz ^b   Barrera, Lucía ^b   Alemán, Mercedes ^a   Abatte, Eduardo ^c   Sasiain, María C ^a   De La Barrera, Silvia ^a  

^a INST DE INVEST HEMATOLOGICAS   (Argentina)

^b INSTITUTO NACIONAL DE ENFERMEDADES INFECCIOSAS   (Argentina)

^c HOSPITAL F J MUÑIZ   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; TRANSCRIPTION FACTOR FOXP3;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC LYMPHOCYTE; EPIDEMIC; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNITY; MACROPHAGE; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS M; MYCOBACTERIUM TUBERCULOSIS RA; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH1 CELL;

ARGENTINA; CYTOKINES; DISEASE OUTBREAKS; FLOW CYTOMETRY; HUMANS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 70350442293     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00224-09     Document Type: Article

References (60)

1. Aita, J., L. Barrera, A. Reniero, B. López, J. Biglione, G. Weisburd, J. C. Rajmil, C. Largacha, and V. Ritacco. 1996. Hospital transmission of multidrug-resistant Mycobacterium tuberculosis in Rosario, Argentina. Medicina (Buenos Aires) 56:48-50.
2. Betts, M. R., J. M. Brenchley, D. A. Price, S. C. De Rosa, D. C. Douek, M. Roederer, and R. A. Koup. 2003. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 281:65-78.
3. Boyum, A. 1968. Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand. J. Clin. Lab. Investig. 97(Suppl.):77-89.
4. Castro, A. Z., B. M. Díaz-Bardalez, E. C. Oliveira, R. C. García, J. B. Afiune, I. A. Paschoal, and L. M. Santos. 2005. Abnormal production of transforming growth factor beta and interferon gamma by peripheral blood cells of patients with multidrug-resistant pulmonary tuberculosis in Brazil. J. Infect. 51:318-324.
5. Caws, M., G. Thwaites, S. Dunstan, T. R. Hawn, N. T. Lan, N. T. Thuong, K. Stepniewska, M. N. Huyen, N. D. Bang, T. H. Loc, S. Gagneux, D. van Soolingen, K. Kremer, M. van der Sande, P. Small, P. T. Anh, N. T. Chinh, H. T. Quy, N. T. Duyen, D. Q. Tho, N. T. Hieu, E. Torok, T. T. Hien, N. H. Dung, N. T. Nhu, P. M. Duy, N. van Vinh Chau, and J. Farrar. 2008. The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathog. 4:e1000034. (Pubitemid 351631085)
6. Chen, X., B. Zhou, M. Li, Q. Deng, X. Wu, X. Le, C. Wu, N. Larmonier, W. Zhang, H. Zhang, H. Wang, and E. Katsanis. 2007. CD4(+)CD25(+)FoxP3(+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease. Clin. Immunol. 123:50-59.
7. Cosmi, L., F. Liotta, R. Angeli, B. Mazzinghi, V. Santarlasci, R. Manetti, L. Lasagni, V. Vanini, P. Romagnani, E. Maggi, F. Annunziato, and S. Romagnani. 2004. Th2 cells are less susceptible than Th1 cells to the suppressive activity of CD25+ regulatory thymocytes because of their responsiveness to different cytokines. Blood 103:3117-3121. (Pubitemid 38451689)
8. Cosmi, L., F. Liotta, E. Lazzeri, M. Francalanci, R. Angeli, B. Mazzinghi, V. Santarlasci, R. Manetti, V. Vanini, P. Romagnani, E. Maggi, S. Romagnani, and F. Annunziato. 2003. Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes. Blood 102:4107-4114.
9. Davies, P., and J. Grange. 2001. The genetics of host resistance and susceptibility to tuberculosis. Ann. N. Y. Acad. Sci. 953:151-156.
10. de la Barrera, S., M. Aleman, R. Musella, P. Schierloh, V. Pasquinelli, V. García, E. Abbate, and C. Sasiain Mdel. 2004. IL-10 down-regulates costimulatory molecules on Mycobacterium tuberculosis-pulsed macrophages and impairs the lytic activity of CD4 and CD8 CTL in tuberculosis patients. Clin. Exp. Immunol. 138:128-138.
11. de la Barrera, S., S. Fink, M. Finiasz, F. Minnucci, R. Valdez, L. M. Balina, and M. C. Sasiain. 1995. Lack of cytotoxic activity against Mycobacterium leprae 65-kD heat shock protein (hsp) in multibacillary leprosy patients. Clin. Exp. Immunol. 99:90-97.
12. de La Barrera, S. S., M. Finiasz, A. Frias, M. Aleman, P. Barrionuevo, S. Fink, M. C. Franco, E. Abbate, and M. del Carmen Sasiain. 2003. Specific lytic activity against mycobacterial antigens is inversely correlated with the severity of tuberculosis. Clin. Exp. Immunol. 132:450-461.
13. Dlugovitzky, D., M. L. Bay, L. Rateni, L. Urizar, C. F. Rondelli, C. Largacha, M. A. Farroni, O. Molteni, and O. A. Bottasso. 1999. In vitro synthesis of interferon-gamma, interleukin-4, transforming growth factor-beta and interleukin- 1 beta by peripheral blood mononuclear cells from tuberculosis patients: relationship with the severity of pulmonary involvement. Scand. J. Immunol. 49:210-217.
14. Dye, C., and B. G. Williams. 2000. Criteria for the control of drug-resistant tuberculosis. Proc. Natl. Acad. Sci. USA 97:8180-8185.
15. Fontenot, J. D., M. A. Gavin, and A. Y. Rudensky. 2003. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4:330-336.
16. Fortes, A., K. Pereira, P. R. Antas, C. L. Franken, M. Dalcolmo, M. M. Ribeiro-Carvalho, K. S. Cunha, A. Geluk, A. Kritski, A. Kolk, P. Klatser, E. N. Sarno, T. H. Ottenhoff, and E. P. Sampaio. 2005. Detection of in vitro interferon-gamma and serum tumour necrosis factor-alpha in multidrug-resistant tuberculosis patients. Clin. Exp. Immunol. 141:541-548.
17. Garg, A., P. F. Barnes, S. Roy, M. F. Quiroga, S. Wu, V. E. García, S. R. Krutzik, S. E. Weis, and R. Vankayalapati. 2008. Mannose-capped lipoarabinomannan- and prostaglandin E2-dependent expansion of regulatory T cells in human Mycobacterium tuberculosis infection. Eur. J. Immunol. 38:459-469.
18. Guyot-Revol, V., J. A. Innes, S. Hackforth, T. Hinks, and A. Lalvani. 2006. Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. Am. J. Respir. Crit. Care Med. 173:803-810.
19. Hougardy, J. M., S. Place, M. Hildebrand, A. Drowart, A. S. Debrie, C. Locht, and F. Mascart. 2007. Regulatory T cells depress immune responses to protective antigens in active tuberculosis. Am. J. Respir. Crit. Care Med. 176:409-416.
20. Hougardy, J. M., V. Verscheure, C. Locht, and F. Mascart. 2007. In vitro expansion of CD4+CD25highFOXP3+CD127low/-regulatory T cells from peripheral blood lymphocytes of healthy Mycobacterium tuberculosis-infected humans. Microbes Infect. 9:1325-1332.
21. Joosten, S. A., and T. H. Ottenhoff. 2008. Human CD4 and CD8 regulatory T cells in infectious diseases and vaccination. Hum. Immunol. 69:760-770.
22. Joosten, S. A., K. E. van Meijgaarden, N. D. Savage, T. de Boer, F. Triebel, A. van der Wal, E. de Heer, M. R. Klein, A. Geluk, and T. H. Ottenhoff. 2007. Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4. Proc. Natl. Acad. Sci. USA 104:8029-8034.
23. Kamerbeek, J., L. Schouls, A. Kolk, M. van Agterveld, D. van Soolingen, S. Kuijper, A. Bunschoten, H. Molhuizen, R. Shaw, M. Goyal, and J. van Embden. 1997. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J. Clin. Microbiol. 35:907-914.
24. Kaufmann, S. H. 2001. How can immunology contribute to the control of tuberculosis? Nat. Rev. Immunol. 1:20-30.
25. Lee, J. S., C. H. Song, C. H. Kim, S. J. Kong, M. H. Shon, H. J. Kim, J. K. Park, T. H. Paik, and E. K. Jo. 2002. Profiles of IFN-gamma and its regulatory cytokines (IL-12, IL-18 and IL-10) in peripheral blood mononuclear cells from patients with multidrug-resistant tuberculosis. Clin. Exp. Immunol. 128:516-524.
26. Lee, J. S., C. H. Song, J. H. Lim, H. J. Kim, J. K. Park, T. H. Paik, C. H. Kim, S. J. Kong, M. H. Shon, S. S. Jung, and E. K. Jo. 2003. The production of tumour necrosis factor-alpha is decreased in peripheral blood mononuclear cells from multidrug-resistant tuberculosis patients following stimulation with the 30-kDa antigen of Mycobacterium tuberculosis. Clin. Exp. Immunol. 132:443-449.
27. Loddenkemper, R., D. Sagebiel, and A. Brendel. 2002. Strategies against multidrug-resistant tuberculosis. Eur. Respir. J. 36(Suppl.):66s-77s.
28. López, B., D. Aguilar, H. Orozco, M. Burger, C. Espitia, V. Ritacco, L. Barrera, K. Kremer, R. Hernandez-Pando, K. Huygen, and D. van Soolingen. 2003. A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes. Clin. Exp. Immunol. 133:30-37.
29. López, B. G., C. Latini, M. Ambroggi, E. Gravina, V. Ritacco, and L. Barrera. 2008. Two M. tuberculosis lineages are over represented among new cases of MDR and XDR TB in Argentina. Int. J. Tuberc. Lung Dis. 12(Suppl. 2):S173.
30. Manca, C., M. B. Reed, S. Freeman, B. Mathema, B. Kreiswirth, C. E. Barry III, and G. Kaplan. 2004. Differential monocyte activation underlies strain-specific Mycobacterium tuberculosis pathogenesis. Infect. Immun. 72:5511-5514.
31. Manca, C., L. Tsenova, S. Freeman, A. K. Barczak, M. Tovey, P. J. Murray, C. Barry, and G. Kaplan. 2005. Hypervirulent M. tuberculosis W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway. J. Interferon Cytokine Res. 25:694-701. (Pubitemid 43010524)
32. Matteelli, A., G. B. Migliori, D. Cirillo, R. Centis, E. Girard, and M. Raviglion. 2007. Multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis: epidemiology and control. Expert Rev. Anti Infect. Ther. 5:857-871.
33. McDyer, J. F., M. N. Hackley, T. E. Walsh, J. L. Cook, and R. A. Seder. 1997. Patients with multidrug-resistant tuberculosis with low CD4+ T cell counts have impaired Th1 responses. J. Immunol. 158:492-500.
34. Mempel, T. R., M. J. Pittet, K. Khazaie, W. Weninger, R. Weissleder, H. von Boehmer, and U. H. von Andrian. 2006. Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. Immunity 25:129-141.
35. Ordway, D. J., L. Costa, M. Martins, H. Silveira, L. Amaral, M. J. Arroz, F. A. Ventura, and H. M. Dockrell. 2004. Increased interleukin-4 production by CD8 and gammadelta T cells in health-care workers is associated with the subsequent development of active tuberculosis. J. Infect. Dis. 190:756-766.
36. Ormerod, L. P. 2005. Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment. Br. Med. Bull. 73-74:17-24.
37. Palmero, D., V. Ritacco, M. Ambroggi, N. Marcela, L. Barrera, L. Capone, A. Dambrosi, M. di Lonardo, N. Isola, S. Poggi, M. Vescovo, and E. Abbate. 2003. Multidrug-resistant tuberculosis in HIV-negative patients, Buenos Aires, Argentina. Emerg. Infect. Dis. 9:965-969.
38. Palmero, D., V. Ritacco, S. Ruano, M. Ambroggi, L. Cusmano, M. Romano, Z. Bucci, and J. Waisman. 2005. Multidrug-resistant tuberculosis outbreak among transvestite sex workers, Buenos Aires, Argentina. Int. J. Tuberc. Lung Dis. 9:1168-1170.
39. Palmero, D. J., M. Ambroggi, A. Brea, M. De Lucas, A. Fulgenzi, D. Martínez, C. Mosca, R. Musella, M. Natiello, C. González, and E. Abbate. 2004. Treatment and follow-up of HIV-negative multidrug-resistant tuberculosis patients in an infectious diseases reference hospital, Buenos Aires, Argentina. Int. J. Tuberc. Lung Dis. 8:778-784.
40. Rajashree, P., and S. D. Das. 2008. Infection with prevalent clinical strains of Mycobacterium tuberculosis leads to differential maturation of monocyte derived dendritic cells. Immunol. Lett. 117:174-180.
41. Rajavelu, P., and S. D. Das. 2003. Cell-mediated immune responses of healthy laboratory volunteers to sonicate antigens prepared from the most prevalent strains of Mycobacterium tuberculosis from South India harboring a single copy of IS6110. Clin. Diagn. Lab. Immunol. 10:1149-1152.
42. Rajavelu, P., and S. D. Das. 2005. Th2-type immune response observed in healthy individuals to sonicate antigen prepared from the most prevalent Mycobacterium tuberculosis strain with single copy of IS6110. FEMS Immunol. Med. Microbiol. 45:95-102.
43. Ribeiro-Rodrigues, R., T. Resende Co, R. Rojas, Z. Toossi, R. Dietze, W. H. Boom, E. Maciel, and C. S. Hirsch. 2006. A role for CD4+CD25+ T cells in regulation of the immune response during human tuberculosis. Clin. Exp. Immunol. 144:25-34.
44. Riou, C., A. R. Dumont, B. Yassine-Diab, E. K. Haddad, and R. P. Sekaly. 2006. IL-4 influences the differentiation and the susceptibility to activationinduced cell death of human naive CD8+ T cells. Int. Immunol. 18:827-835.
45. Ritacco, V., M. Di Lonardo, A. Reniero, M. Ambroggi, L. Barrera, A. Dambrosi, B. López, N. Isola, and I. N. de Kantor. 1997. Nosocomial spread of human immunodeficiency virus-related multidrug-resistant tuberculosis in Buenos Aires. J. Infect. Dis. 176:637-642.
46. Roberts, T., N. Beyers, A. Aguirre, and G. Walzl. 2007. Immunosuppression during active tuberculosis is characterized by decreased interferon- gamma production and CD25 expression with elevated forkhead box P3, transforming growth factor-beta, and interleukin-4 mRNA levels. J. Infect. Dis. 195: 870-878.
47. Rook, G. A. 2007. Th2 cytokines in susceptibility to tuberculosis. Curr. Mol. Med. 7:327-337.
48. Sakaguchi, S. 2005. Naturally arising Foxp3-expressing CD25CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6:345-352.
49. Seah, G. T., G. M. Scott, and G. A. Rook. 2000. Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis. J. Infect. Dis. 181:385-389.
50. Shahemabadi, A. S., A. Z. Hosseini, S. Shaghsempour, M. R. Masjedi, M. Rayani, and M. Pouramiri. 2007. Evaluation of T cell immune responses in multi-drug-resistant tuberculosis (MDR-TB) patients to Mycobacterium tuberculosis total lipid antigens. Clin. Exp. Immunol. 149:285-294.
51. Sharma, M. K., A. Al-Azem, J. Wolfe, E. Hershfield, and A. Kabani. 2003. Identification of a predominant isolate of Mycobacterium tuberculosis using molecular and clinical epidemiology tools and in vitro cytokine responses. BMC Infect. Dis. 3:3.
52. Simone, R., A. Zicca, and D. Saverino. The frequency of regulatory CD3+CD8+CD28-CD25+ T lymphocytes in human peripheral blood increases with age. J. Leukoc. Biol. 84:1454-1461.
53. Skapenko, A., J. R. Kalden, P. E. Lipsky, and H. Schulze-Koops. 2005. The IL-4 receptor alpha-chain-binding cytokines, IL-4 and IL-13, induce forkhead box P3-expressing CD25+CD4+ regulatory T cells from CD25-CD4+ precursors. J. Immunol. 175:6107-6116.
54. Smith, S. M., M. R. Klein, A. S. Malin, J. Sillah, K. P. McAdam, and H. M. Dockrell. 2002. Decreased IFN-gamma and increased IL-4 production by human CD8(+) T cells in response to Mycobacterium tuberculosis in tuberculosis patients. Tuberculosis (Edinburgh) 82:7-13.
55. Stenger, S., D. A. Hanson, R. Teitelbaum, P. Dewan, K. R. Niazi, C. J. Froelich, T. Ganz, S. Thoma-Uszynski, A. Melian, C. Bogdan, S. A. Porcelli, B. R. Bloom, A. M. Krensky, and R. L. Modlin. 1998. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 282:121-125. (Pubitemid 28471143)
56. Sun, Y. J., T. K. Lim, A. K. Ong, B. C. Ho, G. T. Seah, and N. I. Paton. 2006. Tuberculosis associated with Mycobacterium tuberculosis Beijing and non-Beijing genotypes: a clinical and immunological comparison. BMC Infect. Dis. 6:105.
57. van Crevel, R., E. Karyadi, F. Preyers, M. Leenders, B. J. Kullberg, R. H. Nelwan, and J. W. van der Meer. Increased production of interleukin 4 by CD4+ and CD8+ T cells from patients with tuberculosis is related to the presence of pulmonary cavities. J. Infect. Dis. 181:1194-1197.
58. van Embden, J. D., M. D. Cave, J. T. Crawford, J. W. Dale, K. D. Eisenach, B. Gicquel, P. Hermans, C. Martin, R. McAdam, T. M. Shinnick, et al. 1993. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J. Clin. Microbiol. 31: 406-409.
59. WHO. 1998. World Health Organization Global Tuberculosis Programme. Laboratory services in tuberculosis control. WHO/TB/98.258. WHO, Geneva, Switzerland.
60. Wolint, P., M. R. Betts, R. A. Koup, and A. Oxenius. 2004. Immediate cytotoxicity but not degranulation distinguishes effector and memory subsets of CD8+ T cells. J. Exp. Med. 199:925-936.